Peripheral Arterial Disease  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Peripheral Arterial Disease
ASPIRE PAD, NCT02317822: Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities

Recruiting
3
400
US
ASA (75-100 mg) + clopidogrel 75 mg: 12m treatment intervention, ASA (75-100 mg) + clopidogrel: 1m (control arm)
University of Texas Southwestern Medical Center
Peripheral Arterial Disease, Antiplatelet Therapy
06/16
06/16

Download Options